OneSource Specialty Pharma partners with Formycon AG to provide integrated biologics manufacturing for biosimilars, supporting global healthcare markets.
Read Morebiosimilars
Emcure Takes Full Ownership of Gennova Biopharmaceuticals, Samit Mehta Named CEO
Gennova Biopharmaceuticals becomes a wholly owned Emcure subsidiary as Samit Mehta takes charge to drive biologics and biosimilars growth.
Read More
Shreehas Tambe Appointed CEO and Managing Director of Biocon Limited Effective April 1, 2026
Shreehas Tambe appointed CEO & MD of Biocon Limited from April 1, 2026, to lead integrated biosimilars and generics business globally.
Read More
Biopharma SHAKTI Announced in Union Budget 2026-27 with ₹10,000 Crore Outlay
Union Budget 2026-27 introduces Biopharma SHAKTI with ₹10,000 crore outlay to boost biologics, biosimilars, healthcare skills and medical hubs.
Read More
Alkem launches Pertuza biosimilar in India for HER2-positive breast cancer treatment
Alkem launches Pertuza biosimilar in India, offering affordable HER2-positive breast cancer treatment and strengthening its oncology portfolio.
Read More
UDENYCA Acquired by Intas Pharmaceuticals and Accord BioPharma in Biosimilar Expansion
UDENYCA, a biosimilar to Amgen’s Neulasta, is indicated to reduce the risk of infection due to febrile neutropenia in patients with non-myeloid malignancies undergoing myelosuppressive chemotherapy.
Read More